Sebela Ireland Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SEBELA IRELAND LTD, and when can generic versions of SEBELA IRELAND LTD drugs launch?
SEBELA IRELAND LTD has seventeen approved drugs.
There are eleven US patents protecting SEBELA IRELAND LTD drugs.
There are eighty-three patent family members on SEBELA IRELAND LTD drugs in thirty-six countries and two supplementary protection certificates in two countries.
Summary for Sebela Ireland Ltd
International Patents: | 83 |
US Patents: | 11 |
Tradenames: | 12 |
Ingredients: | 10 |
NDAs: | 17 |
Drugs and US Patents for Sebela Ireland Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-002 | Jul 3, 2003 | DISCN | Yes | No | 7,598,271 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Sebela Ireland Ltd | PRAMOSONE | hydrocortisone acetate; pramoxine hydrochloride | LOTION;TOPICAL | 085980-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sebela Ireland Ltd | PRAMOSONE | hydrocortisone acetate; pramoxine hydrochloride | CREAM;TOPICAL | 083778-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 204286-001 | Jun 27, 2013 | AB | RX | Yes | Yes | 10,729,667 | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | CREAM;TOPICAL | 019599-001 | Feb 29, 1988 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sebela Ireland Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-001 | Jul 3, 2003 | 5,874,447 | ⤷ Try a Trial |
Sebela Ireland Ltd | ONMEL | itraconazole | TABLET;ORAL | 022484-001 | Apr 29, 2010 | 8,591,948 | ⤷ Try a Trial |
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | 4,414,209 | ⤷ Try a Trial |
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | 4,225,597 | ⤷ Try a Trial |
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-001 | Jul 3, 2003 | 6,703,408 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SEBELA IRELAND LTD drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 0.5 mg and 1 mg | ➤ Subscribe | 2010-12-02 |
➤ Subscribe | Capsules | 7.5 mg | ➤ Subscribe | 2014-04-07 |
International Patents for Sebela Ireland Ltd Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Poland | 2068881 | ⤷ Try a Trial |
Estonia | 03970 | ⤷ Try a Trial |
Singapore | 176452 | ⤷ Try a Trial |
Slovenia | 2068881 | ⤷ Try a Trial |
Bulgaria | 64315 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sebela Ireland Ltd Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.